Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
30 April 2024 - LB024
Exploring the efficacy of plasma exchange therapy in post-COVID-19 condition: a pilot randomised double-blind trial
Sergio España-Cueto, Cristina López, Cora Loste, Gemma Lladós-Bertran, José Ramón Santos, Gemma Dulsat, Anna García, Júlia Carabia, Águeda Ancochea, Anna Sánchez, Ivonne Graciela Parraga, Anna Chamorro, Alba San José, Elena Abad, José A. Muñoz, Anna Prats, Joao Pedro Carmezim, Cristian Tebe, M. Carmen Rodríguez, Roser Coll, Carla Estany, Jordi Puig, Bonaventura Clotet, Marta Massanella, Roger Paredes, Lourdes Mateu Prunonosa,
30 April 2024 - LB049
Olgotrelvir as a standalone treatment for non-hospitalised COVID-19 patients: a Phase III, double-blind, randomised, placebo-controlled trial
Rongmeng Jiang, Bing Han, Wanhong Xu, Xiaoying Zhang, Chunxian Peng, Qiang Dang, Wei Sun, Ling Lin, Yuanlong Lin, Lingyan Fan, Dongqing Lv, Lei Shao, Ying Chen, Yunqing Qiu, Limei Han, Weixiang Kong, Guangming Li, Kai Wang, Jie Peng, Bingliang Lin, Zhaowei Tong, Xiaobo Lu, Lifang Wang, Feng Gao, Jiemei Feng, Yongxia Li, Xiaojun Ma, Jinxiang Wang, Shanbo Wang, Wei Shen, Chao Wang, Kuan Yan, Zhenhao Lin, Can Jin, Long Mao, Jia Liu, Henry Ji, Xiao Xu, Hongzhou Lu
30 April 2024 - LB046
Immunogenicity and reactogenicity of fractional vs full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, Phase 4 clinical trial in Brazil
Marco Antônio Puga, Roberto Oliveira, Patricia Vieira, Vivek Charu, Haley Hedlin, Di Lu, Amy Zhang, Blake Shaw, Joelle Rosser, Jessica Seidman, Alice Carter, Farah Qamar, Stephen Luby, Denise Garrett, Julio Croda,
30 April 2024 - O1180
Efficacy and safety of ibezapolstat compared with vancomycin for the treatment of Clostridioides difficile infection: a Phase II, randomised, double-blind study
Kevin Garey, M. Jahangir Alam, Khurshida Begum, Jacob Mcpherson, Taryn Eubank, Michael Silverman
28 April 2024 - E0464
Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease 4 (FEXI-12): a Phase II, double-blind, multi-centre randomised trial
María Jesús Pinazo, Colin Forsyth, Irene Losada Galvan, Elena Trigo Esteban, Magda García Rodrígez, María Luz Villegas, Israel Molina, Clara Crespillo Andújar, Montserrat Gállego, Cristina Ballart, Juan Carlos Ramírez, Tilman Aden, Achim Hoerauf, Kenneth Pfarr, Michel Vaillant, Tayná Marques, Jayme Fernandes, Bethania Blum, Isabela Ribeiro, Sergio Sosa-Estani, Fabiana Barreira, Joaquim Gascón,
28 April 2024 - P0774
Comparison of ceftobiprole versus daptomycin for time to S. aureus bloodstream clearance in the recent double-blind randomised Phase 3 study (ERADICATE)
Thomas Holland, Sara Cosgrove, Sarah Doernberg, Timothy Jenkins, Nicholas Turner, Helen Boucher, Mark Jones, Daniel Ionescu, Jennifer Smart, Mikael Saulay, Marc Engelhardt, Vance Fowler
28 April 2024 - O0522
Interferon-a (IFN-a) nasal spray as prophylaxis reduces the incidence of COVID-19 in cancer patients: a randomised double-blinded placebo-controlled study (The C-SMART Trial)
Michelle Yong, Karin Thursky, Megan Crane, Tim Spelman, Robert Mahar, Julie Simpson, Andrew Scott, Simon Harrison, Jeff Szer, Marc Pellegrini, Senthil Lingaratnam, Ken Pang, Surekha Tennakoon, Emily Blyth, Hui Gan, Hang Quach, Michelle Mcintosh, Hayley Page, Rachel Woolstencroft, Monica Slavin,
28 April 2024 - O0685
Effect of the 13-valent pneumococcal conjugate vaccine on cardiovascular mortality: a post hoc analysis of a double-blind randomised placebo-controlled study
Annabel Niessen, Annemarijn De Boer, Marc Bonten, Henri Van Werkhoven
28 April 2024 - P0771
An analysis of baseline conditions or complications of S. aureus bacteraemia from a double-blind, randomised Phase 3 study (ERADICATE) comparing ceftobiprole vs daptomycin
Thomas Holland, Sara Cosgrove, Sarah Doernberg, Timothy Jenkins, Nicholas Turner, Helen Boucher, Mark Jones, Daniel Ionescu, Jennifer Smart, Mikael Soulay, Marc Engelhardt, Vance Fowler
28 April 2024 - P2546
Chronic Pseudomonas aeruginosa pulmonary infection treated with a nebulised phage cocktail in patients with cystic fibrosis: a phase 1b/2a randomised, double-blind, placebo-controlled, multicentre study
Urania Rappo, Ariel Cohen, Iris Maimon, Edith Kario, Jenia Gold, Hadas-Tamar Nevenzal, Inbal Levy-Saar, Tal Cohen, Iddo Nadav Weiner, Hila Sberro Livnat, Ilya Vainberg Slutskin, Jagoda Jablonska, Ron Mordoch, Tim Axelrod, Ori Bahar, Nufar Buchshtab, Vered Lev, Yaron Tzur, Yulia Zarchin, Myriam Golembo, Regis Vilchez, Eitan Kerem, Merav Bassan
27 April 2024 - P0200
Effect of montelukast in preventing dengue with warning signs among patients with dengue: a multicentre, randomised, double-blind, placebo-controlled trial
Nattapat Nitinai, Worapong Nasomsong, Worayon Chuerboonchai, Akarawin Tweekittikul, Vutthikorn Khingmontri, Bawornnan Panuvatvanich, Thananut Bangchuad, Maynanchaya Pongpraijaroen, Tanapol Roongfa-Ngarm, Vasin Vasikasin,
27 April 2024 - P0398
Local and systemic reactogenicity after mRNA and protein-based COVID vaccines compared to meningococcal vaccine (MenACWY) in a UK blinded, randomised phase 2 trial (COV-BOOST)
Anthony Marchese, Hadi Beyhaghi, Matthew Rousculp, Xinxue Liu, Toback Seth, Saul Faust
27 April 2024 - P0408
A Randomized, Double-Blinded, Cohort Clinical Trial on Evaluating the Safety and Immunogenicity of Sequential Immunization of Two Doses of Omicron Specific Inactivated COVID-19 Vaccines as Boosters in Adults
Ruiqi Zhang, Xiaoming Yang, Anthony Raymond Tam, Edwin Wing-Ming Chu, Gary Kui-Kai Lau, Yuntao Zhang, Yunkai Yang, Henry Kwong-Chi Yau, Creany Ka-Wai Wong, Chi-Tao Ng, Tsz-Shing Hui, Hui Wang, Kai Duan, Wei Wang, Yang Liu, Qingliang Li, Kelvin Kai-Wang To, Kwok-Hung Chan, Dong-Yan Jin, Kwok-Yung Yuen, Fan-Ngai Ivan Hung
18 April 2023 - P3155
Not in the blink of an eye: a case of chronic keratoconjunctivitis of unknown origin finally attributed to monkeypox
Astrid Füszl, Julia Ebner, Miriam Van Den Nest, Lukas Bouvier-Azula, Philipp Roberts, Magda Diab-Elschahawi, Elisabeth Presterl
18 April 2023 - LB021
Trial in progress: a phase I/III, randomised, modified double-blind, placebo- and active-controlled pre-exposure prophylaxis study of the SARS-CoV-2–neutralising antibody AZD3152 (SUPERNOVA)
Chris Webber, Rohini Beavon, Steven Thomas, Lee-Jah Chang, Taylor S. Cohen, John L. Perez
17 April 2023 - P2235
Pharmacokinetics and safety of daptomycin administered subcutaneously in healthy volunteers: a single-blinded randomised cross-over trial
Charles Maurille, Marie-Clémence Verdier, Christian Creveuil, Jean-Jacques Parienti, Jocelyn Michon, Laure Peyro-Saint-Paul, Sylvie Brucato, Sylvie Dargère, Aurélie Baldolli, Renaud Verdon
17 April 2023 - E0894
Randomised double-blind study to determine multiple doses, safety and tolerability of TP-102 bacteriophage cocktail in subjects with non-infected and infected diabetic foot ulcers
Ran Nir-Paz, Hadil Onallah, Michal Dekel, Yechiel N. Gellman, Amir Haze, Yonatan Oster, Ronen Ben-Ami, Ron Braunstein, Ronen Hazan, Clara Leandro, Raquel Barbosa, Helena Dorido, Alexandra Wagner, Daniela Jones-Dias, Susana Gonçalves, Margarida Barreto, Sofia Corte-Real, Miguel Garcia
17 April 2023 - O0921
Ceftriaxone to prevent early ventilator-acquired pneumonia in comatose brain-injured patients: a multicenter, randomised, double-blind, placebo-controlled trial
Claire Dahyot-Fizelier, Sigismond Lasocki, Karim Ashenoune, Pierre-François Perrigault, Thomas Geeraerts, Yoann Launey, Vincent Cottenceau, Djilali Elaroussi, Thomas Kerforne, Denis Frasca, Olivier Mimoz
17 April 2023 - P2629
Bemnifosbuvir (AT-527) treatment of non-hospitalized individuals with mild to moderate COVID-19: results from a truncated phase 3, randomized, double-blind, placebo-controlled trial (MORNINGSKY)
Maria Arantxa Horga, Rebecca Saenz, Keith Pietropaolo, William Stubbings, Neil Collinson, Laura Ishak, Barbara Zrinscak, Bruce Belanger, Catherine Granier, Kai Lin, Aeron Hurt, Xiao-Jian Zhou, Steffen Wildum, Janet Hammond
17 April 2023 - P2698
Interim analysis of an observer-blinded, randomized phase 3 study to evaluate the safety and immunogenicity of a single booster of the NVX-CoV2373 vaccine in adults previously vaccinated with the BBIBP-CorV vaccine
Seth Toback, Anthony Marchese, Nawal Al Kaabi, Salah Hussein, Agyad Bakkour, Maria-Fernanda Bonilla, Fahed Almarzooqi, Islam Eltantawy, Bartlomiej Piechowski-Jozwiak, Matthew Rousculp
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.